No additional funding?!! R&D will continue CR will most likely be required for Ph2b, because R&D tax rebates won't cut it
This current commercial position is driving down the sp!!! I'm still in it but have reduced my holdings considerably due this sentiment and trend. If it continues over the next 3-5months we'll be looking at 4-3c again. The possibility of dilution and a reduced sp will be a knee to the gut
Poor form from MnM who publicly stated that she thinks the market cap of the company should be over $200m. Well the market thinks its unsubstantiated....prove us all wrong but don't let the sp dwindle otherwise its totally unprofessional, absurd and unethical statement to make!
Highlighting that 'Multiple partnering opportunities across Biotron’s portfolio' is misleading, and unsubstantiated without providing target milestones! The market is starting to think its YEARS away!
BIT Price at posting:
8.4¢ Sentiment: None Disclosure: Held
